Boldine inhibits SARM1 NADase Activity and Preserves Axonal Integrity After Nerve Injury
Burrell, J. C.; Latona, T. T.; Garcia, H.; Clizbe, D. R.; Tatarchuk, M. M.; Zhou, L.; Toro, C. A.; Olivarez, A. N.; Nguyen, P. V.; Yang, C. Z.; Bittner, G. D.; Cardozo, C. P.; Cullen, D. K.
Show abstract
Wallerian degeneration of anucleated axonal segments is driven by SARM1, which depletes axonal NAD+, disrupting energy metabolism and triggering self-destruction. SARM1 inhibition is an emerging therapeutic target for traumatic nerve injuries. Boldine, a natural aporphine alkaloid from Peumus boldus, modulates connexin hemichannels, oxidative stress, and inflammation. Building on our published work showing boldines neuroprotective effects in nerve injury models, we hypothesized that boldine also inhibits SARM1 directly. A fluorescence polarization assay revealed that boldine inhibits SARM1 NADase activity with an IC50 of approximately 7.5 uM. AI-assisted structural modeling (AlphaFold3-based Boltz-1 with GNINA docking) predicted two boldine binding sites on SARM1: the TIR catalytic site (Kd [~] 13.5 uM) and the ARM-TIR regulatory interface (Kd [~] 12 uM). In a sciatic nerve explant model, boldine preserved the integrity of anucleated axonal segments at 3 and 7 days post-transection relative to vehicle controls. These findings suggest boldine may act as a dual-site SARM1 inhibitor and support its development as a neuroprotective therapy after traumatic axonal injury.
Matching journals
The top 14 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Exifone is a Potent HDAC1 Activator with Neuroprotective Activity in Human Neuronal Models of Neurodegeneration 94%
- Nicotinic acetylcholine receptor partial antagonist polyamides from tunicates and their predatory sea slugs 93%
- Molecular pharmacology of selective NaV1.6 and dual NaV1.6 and NaV1.2 channel inhibitors that suppress excitatory neuronal activity ex vivo 93%
Similar papers in this journal
- Covalent inhibition of the SARS-CoV-2 NiRAN domain via an active-site cysteine 93%
- Development of FERM domain protein-protein interaction inhibitors for MSN and CD44 as a potential therapeutic strategy for Alzheimer's disease. 93%
- Multimodal small-molecule screening for human prion protein binders 93%
Similar papers in this journal
- Nanocatalytic activity of clean-surfaced, faceted nanocrystalline gold enhances remyelination in animal models of multiple sclerosis 94%
- Novel Adult Cortical Neuron Processing and Screening method illustrates Sex- and Age-dependent effects of pharmaceutical compounds 94%
- Identification of Small Molecule Dimethyoxyphenyl Piperazine Inhibitors of Alpha-Synuclein Fibril Growth 93%
Similar papers in this journal
- Protein mimetic amyloid inhibitor potently abrogates cancer-associated mutant p53 aggregation and restores tumor suppressor function 94%
- Enhancing Intracellular Accumulation and Target Engagement of PROTACs with Reversible Covalent Chemistry 94%
- Small-molecule inhibition of Lats kinases promotes Yap-dependent proliferation in postmitotic mammalian tissues 93%
Similar papers in this journal
- Pathogenic Role of Delta 2 Tubulin in Bortezomib Induced Peripheral Neuropathy 95%
- A novel class of TMPRSS2 inhibitors potently block SARS-CoV-2 and MERS-CoV viral entry and protect human epithelial lung cells 94%
- Thiol-based mucolytics exhibit antiviral activity against SARS-CoV-2 through allosteric disulfide disruption in the spike glycoprotein 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.